CN101199734B - Shuxin capsule for treating cardiac angina induced by CAD - Google Patents
Shuxin capsule for treating cardiac angina induced by CAD Download PDFInfo
- Publication number
- CN101199734B CN101199734B CN 200710199297 CN200710199297A CN101199734B CN 101199734 B CN101199734 B CN 101199734B CN 200710199297 CN200710199297 CN 200710199297 CN 200710199297 A CN200710199297 A CN 200710199297A CN 101199734 B CN101199734 B CN 101199734B
- Authority
- CN
- China
- Prior art keywords
- capsule
- heart disease
- percent
- coronary heart
- shuxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention belongs to the medical preparation, in particular to a Chinese traditional preparation- heart easing pill capsule for treating angina caused by coronary heart disease. The medicine is prepared by Succinum, Cinnabaris, Bulbus Allii and Radix Notoginseng. After observation of 128 cases, the patient who is diagnosed with angina caused by coronary heart disease takes the invention for one month and the general effective rate is 88 percent and the general effective rate of cardiograph efficacy is 66.4 percent. As a pure Chinese herbal preparation, the invention can achieve 66.4 percent cardiograph improvement rate, proving the evident effect of the invention. The observation results show that the invention has more evident effect on three acids glyceride.
Description
Technical field
The invention belongs to a kind of pharmaceutical product, particularly a kind of coronary heart disease for the treatment of causes anginal Chinese medicine preparation.
Background technology
Angina pectoris is a kind of by coronary insufficiency, and the rapid and temporary transient ischemia of cardiac muscle causes the paroxysmal shirtfront and squeezes and feel or pain is the clinical disease of characteristics with anoxia.The outbreak of primary disease many tired, exciting, catch cold, be satiated with food, during smoking.
The most frequently used method is to take nitroglycerine tablets.In addition medicine also has beta-Blocking agent such as propranolol, calcium ion antagonist such as nifedipine, diltiazem.At present, nitroglycerin has had membranous patch and oral spray.Membranous patch is used in left front chest outward, and medicine evenly absorbs through skin, continues the antianginal effect of performance in 24 hours.Oral spray is then little because of consumption, absorbs sooner, and side effect is little and be subjected to patient and welcome.More than these two kinds of dosage form prices more expensive, be unfavorable for promoting the use of.
SUXIAO JIUXIN WAN is a Chinese medicine preparation, take during angina pectoris attacks in the 10-15 grain number minute and take effect, this medicine also can be taken for a long time. and other are taken for a long time as medicines such as storax pill for treating coronary heart disease, FUFANG DANSHEN PIAN, Xinnao Shutongs, can play the effect of the logical coronary circulation of relaxing, generally select wherein 1,2 kind for use according to self-condition.
Though the satisfied medicine of angina pectoris therapeutic effect is various in style, though long-acting single nitro isosorbide can be kept nearly 20 hours of effect, but clinical practice still has certain disadvantage, and external product costs an arm and a leg, and how patient's side effect such as excuse pain, flush sometimes can not bear.
Summary of the invention
The object of the invention provides a kind of treatment coronary heart disease and causes anginal comfortable capsule.
Specifically, to cause anginal comfortable capsule be that monarch drug is made by succinum, Cinnabaris, Bulbus Allii, Herba Sedi Aizoon to treatment coronary heart disease.
The proportioning that the present invention recommends is: succinum, Cinnabaris, Bulbus Allii, Herba Sedi Aizoon equal portions are made.
Advantage of the present invention is that compatibility is simple, does not have toxic and side effects.
The specific embodiment
Method for making: succinum, Cinnabaris, Bulbus Allii, Herba Sedi Aizoon equal portions grind face altogether, adorn capsule No. 0, and every contains former medicine 0.45 gram.
Cure mainly: coronary heart disease causes angina pectoris.
Effect: activating blood circulation to dissipate blood stasis, tranquillizing and allaying excitement.
Indication: shortness of breath and palpitation, insomnia uncomfortable in chest.
Instructions of taking: each 2, every day 2 times.
The side separates: the succinum activating blood circulation to dissipate blood stasis, and tranquillizing and allaying excitement, Cinnabaris tranquillization with heavy prescription detoxifcation, the Bulbus Allii detoxifcation of being good for the stomach has the effect that reduces cholesterol in the blood, complete square shared have activating blood circulation to dissipate blood stasis refreshment pain relieving, the merit of calming the nerves.
It is routine existing as follows with the observed result comprehensive dispatch that altogether observe angina pectoris 128 from year August in April to 2007 in January, 2006:
One, physical data
128 routine patients with coronary heart disease male 79, women 49 people, age 45-76 year (average 58.3 years old) 99 routine complicated hypertension histories, the course of disease mostly is 3-8 greatly, 43 examples＞10 year.
Coronary heart disease stable angina pectoris 78 examples, unstable angina 29 examples, angina pectoris 11 examples behind the heart infarction, not quite clear 10 examples.The angina pectoris degree is sought unity of standard according to domestic therapy of combining Chinese and Western medicine angina pectoris cooperative groups, slight 46 examples; Moderate 59 examples; Severe 23 examples.128 examples observe cases due to illness feelings need contain the nitroglycerin simultaneously the person counts 97 people,＜3 slices/day, electrocardiogram has in various degree that ST-T changes before the 112 example treatments.
Two, observational technique
Filling in unified observation table is observed by the special messenger, stop any at least one week of angina pectoris medicine, the nitroglycerin tongue contains exception need count item records such as consumption every day (sheet/day) treatment before measurement platelet white blood cell count, GPT, blood glucose, BUN, creatinine, routine urinalysis, cholesterol, triglyceride and high density lipoprotein, electrocardiogram, 2 of each oral Shuxin pill capsules, one twice-daily, one week was a course of treatment, the above-mentioned item inspection of treatment back check, and the unification of observation table is gathered to array data by the special messenger makes brief summary.
Three, curative effect judging standard
Produce effects: " breathe hard, pained transference cure or obviously alleviate, other double disease and electrocardiogram are stable or progressive to some extent.
Invalid: all diseases and electrocardiogram no change;
Four, result
1, therapeutic effect: angina pectoris clinical symptoms curative effect obvious effective rate is 88%; Electrocardiogram improves effective percentage, obvious effective rate 21.4%, total effective rate 66.4%.
2, adverse reactions of patients.In 128 examples only 1 example have epigastric discomfort to feel sick, the loss of appetite untoward reaction does not influence medication treatment, alleviates disappearance in the drug administration process gradually, does not have that other is unusual.
3, lab testing has no significant change before and after all other treatments.
Four, discuss
Through observing 128 examples, be diagnosed as that a month angina pectoris total effective rate is 88% behind the angina pectoris case clothes capsule of the present invention of coronary heart disease; The ECG curative effect total effective rate is 66.4%, can reach 66.4% as the pure Chinese medicinal preparation month electrocardiogram improvement rate of taking medicine, and illustrates that drug effect is remarkable.Blood fat is also felt quite pleased.
Claims (1)
1. treatment coronary heart disease causes anginal comfortable capsule, it is characterized in that being made by succinum, Cinnabaris, Bulbus Allii, Herba Sedi Aizoon equal portions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200710199297 CN101199734B (en) | 2007-12-05 | 2007-12-05 | Shuxin capsule for treating cardiac angina induced by CAD |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200710199297 CN101199734B (en) | 2007-12-05 | 2007-12-05 | Shuxin capsule for treating cardiac angina induced by CAD |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101199734A CN101199734A (en) | 2008-06-18 |
| CN101199734B true CN101199734B (en) | 2010-06-09 |
Family
ID=39515217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200710199297 Expired - Fee Related CN101199734B (en) | 2007-12-05 | 2007-12-05 | Shuxin capsule for treating cardiac angina induced by CAD |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101199734B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1247760A (en) * | 1999-09-09 | 2000-03-22 | 袁双田 | Heart disease treating medicine |
| CN1444965A (en) * | 2003-04-16 | 2003-10-01 | 吉林市中心医院 | Medicine for treating heart disease |
-
2007
- 2007-12-05 CN CN 200710199297 patent/CN101199734B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1247760A (en) * | 1999-09-09 | 2000-03-22 | 袁双田 | Heart disease treating medicine |
| CN1444965A (en) * | 2003-04-16 | 2003-10-01 | 吉林市中心医院 | Medicine for treating heart disease |
Non-Patent Citations (2)
| Title |
|---|
| 李中平.育阴扶阳法治疗冠心病体会.湖南中医杂志20 1.2004,20(1),10-11. |
| 李中平.育阴扶阳法治疗冠心病体会.湖南中医杂志20 1.2004,20(1),10-11. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101199734A (en) | 2008-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101584797B (en) | Application of traditional Chinese medicine composition in preparing medicament for treating climacteric syndrome | |
| JP2013532666A (en) | Anti-fatigue composition, its formulation and application | |
| WO2010009582A1 (en) | Medical footwear | |
| CN102283940B (en) | Chinese medicinal preparation for treating palpitation | |
| CN101199734B (en) | Shuxin capsule for treating cardiac angina induced by CAD | |
| CN103385963B (en) | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease | |
| CN101167838B (en) | Traditional Chinese medicinal preparation for treating coronary heart disease and angina pectoris and its preparing process | |
| CN100457144C (en) | Compound capsule of Chinese date kernel, and preparation method | |
| CN102579804B (en) | Chinese medicine for treating stenocardia | |
| Kong et al. | Safety of individual medication of Ma Qian Zi (semen strychni) based upon assessment of therapeutic effects of Guo's therapy against moderate fluorosis of bone | |
| CN101991829B (en) | Medicament for treating stomach illness | |
| CN101313990B (en) | Application of a Chinese medicinal composition in preparing medicament for treating neurosis | |
| CN101422489A (en) | Traditional Chinese medicine preparation for treating adenocarcinoma | |
| CN103720810A (en) | Medicine for treating qi-stagnation and blood stasis coronary heart disease and complication of disease and preparation method of medicine | |
| CN103251891A (en) | Chinese medicinal external-application ointment for treating qi-stagnation and blood stasis type unstable angina | |
| CN100571722C (en) | Treatment is suffered from a deficiency of the kidney and the pharmaceutical composition of climacteric syndrome and preparation method thereof | |
| CN101797330B (en) | Lipid regulating and meridians activating capsule | |
| CN102430040A (en) | Medicament for treating diabetes | |
| CN113413445B (en) | Composition and preparation method and application thereof | |
| CN102716260A (en) | Medicine for fast improving sperm quality and sexual function | |
| CN102772540B (en) | A kind of medicine for the treatment of metabolism syndrome | |
| CN105709228A (en) | Medicine composition used for treating myocardial ischemia and preparation method thereof | |
| CN104825682A (en) | Traditional Chinese medicine for treatment of coronary heart disease angina pectoris | |
| CN103479712B (en) | Traditional Chinese medicine composition for treating coronary heart disease angina and application thereof | |
| CN104623282A (en) | Traditional Chinese medicine healthy preparation for conditioning hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100609 Termination date: 20101205 |